Virbac Chooses Paul Hays To Head U.S. Commercial Operations

Posted: Dec. 18, 2012, 12:30 p.m. EST



Published:

Paul Hays will start Jan. 1 as president of U.S. commercial operations for Virbac Corp.

Former Pfizer Animal Health executive Paul Hays was named president Monday of Virbac Corp.’s U.S. commercial operations.

Hays will oversee sales, marketing, communications and technical services as well as brand management, customer relations and business planning.

Fort Worth, Texas-based Virbac Animal Health manufactures an array of pharmaceutical products for cats, dogs, equine and farm animals, including the heartworm preventive Iverhart, the dermatological shampoo Dermazole and the antibiotic Biomox.

Many Virbac products are sold exclusively through veterinarians.

Hays worked as vice president of global diagnostics at Pfizer Animal Health since 2011, after his previous employer, Synbiotics Corp., where he served as CEO and president, was purchased by Pfizer.

Before joining Synbiotics, Hays was an executive at Boehringer Ingelheim Vetmedica Inc., where he last served as executive vice president of U.S. business operations.

Hays will report to Erik Martinez, CEO of Virbac North America.

“Paul is a seasoned executive and a proven strategic leader with vast experience in managing pharmaceutical businesses, serving both U.S. and global customers and bringing products to market,” Martinez said. “Along with his animal health experience, this makes Paul the perfect leader to reinforce Virbac’s passion for animals and continue Virbac’s legacy of supporting both our veterinarian customers and pet owners.”

<HOME>

Edit Module
Edit ModuleShow Tags

Archive »Read More

K-State Unveils Test for New Dog Flu Strain

The Veterinary Diagnostic Laboratory uses sequencing to identify H3N2 and help in the search for a vaccine.

MSU Names Co-Directors of Veterinary Technology Program

Jolynne Judge, LVT, and Helen Mayer, LVT, bring decades of first-hand experience to the position.

Pets Best Reaches $100 Million in Payouts

The milestone is a victory for pets and a defeat for economic euthanasia, the insurer states.

Add your comment:
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module